Bruker Corporation
BRKR
$44.96
-$0.60-1.32%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 13.56% | 15.26% | 15.19% | 14.77% | 17.49% |
| Total Other Revenue | -- | 47.19% | 27.18% | 9.17% | 47.66% |
| Total Revenue | 13.56% | 15.00% | 14.93% | 14.49% | 17.14% |
| Cost of Revenue | 16.48% | 18.61% | 17.61% | 17.57% | 18.10% |
| Gross Profit | 10.78% | 11.60% | 12.42% | 11.64% | 16.24% |
| SG&A Expenses | 22.65% | 24.79% | 22.14% | 19.25% | 17.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -46.91% | 147.50% | 3,733.33% | 269.09% | 247.27% |
| Total Operating Expenses | 19.42% | 22.14% | 20.50% | 19.54% | 19.34% |
| Operating Income | -16.11% | -19.49% | -10.68% | -7.97% | 7.14% |
| Income Before Tax | -62.43% | -7.95% | 4.68% | 19.27% | 31.65% |
| Income Tax Expenses | -22.34% | -15.58% | -9.27% | -5.94% | 1.12% |
| Earnings from Continuing Operations | -73.44% | -5.49% | 9.63% | 28.46% | 43.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 46.15% | 112.90% | 71.43% | 34.78% | 31.58% |
| Net Income | -73.53% | -4.45% | 10.34% | 28.92% | 44.03% |
| EBIT | -16.11% | -19.49% | -10.68% | -7.97% | 7.14% |
| EBITDA | -1.64% | -4.79% | -0.77% | -1.05% | 10.76% |
| EPS Basic | -73.91% | -4.08% | 11.41% | 30.38% | 46.18% |
| Normalized Basic EPS | -15.79% | -18.19% | -8.35% | -5.41% | 6.09% |
| EPS Diluted | -73.94% | -4.27% | 11.44% | 30.70% | 46.48% |
| Normalized Diluted EPS | -15.68% | -18.06% | -8.23% | -5.33% | 6.19% |
| Average Basic Shares Outstanding | 1.71% | 0.39% | -0.65% | -1.12% | -1.45% |
| Average Diluted Shares Outstanding | 1.58% | 0.24% | -0.78% | -1.18% | -1.52% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 2.88% | 0.06% | -0.09% | -0.23% | -0.32% |
